Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Rnf103em1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Rnf103em1flox/Cya

Common Name
Rnf103-flox
Product ID
S-CKO-06946
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-22644-Rnf103-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Rnf103-flox Mouse (Catalog S-CKO-06946) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Rnf103-flox
Strain ID
CKOCMP-22644-Rnf103-B6J-VA
Gene Name
Rnf103
Product ID
S-CKO-06946
Gene Alias
kf-1, Zfp103
Background
C57BL/6JCya
Gene Full Name
ring finger protein 103
Modification
Conditional knockout
NCBI ID
22644 (Mouse)
Phenotype
MGI:109483
Chromosome
Chr 6 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000064637
NCBI Transcript ID
NM_009543
Target Region
Exon 2
Size of Effective Region
~1.7 kb
Overview of Gene Research
Rnf103, also known as ring finger protein 103, is an E3 ubiquitin-protein ligase. E3 ubiquitin-protein ligases play a crucial role in the ubiquitination process, which is involved in many biological pathways such as protein degradation, cell cycle regulation, and immune response [1,4].

In aquaculture, Rnf103 has been identified as a key target in Vibrio anguillarum immune evasion. It promotes immune escape by inhibiting Traf6. A circular RNA, circRnf103, formed by reverse splicing of the Rnf103 gene, encodes Rnf103-177aa. This protein competes with Rnf103 and binds to Traf6, preventing its degradation. circRnf103 therapy is effective in treating V. anguillarum infections in zebrafish models [1].

In diabetic foot ulcers (DFU), RNF103-CHMP3 (a form related to Rnf103) was identified as a key gene significantly associated with DFU, linked to extracellular interactions and potentially involved in cellular communication and tissue repair mechanisms for wound healing [2].

In Alzheimer's disease, Rnf103 was among six characteristic genes determined by machine-learning algorithms, enabling the prediction of AD progression [3].

In pigs, Rnf103 was considered as a genetic marker for growth traits [5]. In a study on blood lipid levels, Rnf103 was associated with triglycerides [6].

In conclusion, Rnf103 is an important E3 ubiquitin-protein ligase involved in multiple biological processes and diseases. Studies in different models, such as zebrafish for Vibrio infection, have revealed its role in immune-related processes. In diseases like DFU, Alzheimer's, and in relation to lipid metabolism and pig growth, Rnf103 shows potential as a key gene, highlighting its significance in understanding disease mechanisms and potentially developing new treatments.

References:
1. Zheng, Weiwei, Lv, Xing, Tao, Yaqi, Zhu, Tongtong, Xu, Tianjun. 2023. A circRNA therapy based on Rnf103 to inhibit Vibrio anguillarum infection. In Cell reports, 42, 113314. doi:10.1016/j.celrep.2023.113314. https://pubmed.ncbi.nlm.nih.gov/37874674/
2. Yu, Xin, Wu, Zhuo, Zhang, Nan. 2024. Machine learning-driven discovery of novel therapeutic targets in diabetic foot ulcers. In Molecular medicine (Cambridge, Mass.), 30, 215. doi:10.1186/s10020-024-00955-z. https://pubmed.ncbi.nlm.nih.gov/39543487/
3. Lai, Yongxing, Lin, Xueyan, Lin, Chunjin, Chen, Zhihan, Zhang, Li. 2022. Identification of endoplasmic reticulum stress-associated genes and subtypes for prediction of Alzheimer's disease based on interpretable machine learning. In Frontiers in pharmacology, 13, 975774. doi:10.3389/fphar.2022.975774. https://pubmed.ncbi.nlm.nih.gov/36059957/
4. Scheper, Johanna, Oliva, Baldo, Villà-Freixa, Jordi, Thomson, Timothy M. . Analysis of electrostatic contributions to the selectivity of interactions between RING-finger domains and ubiquitin-conjugating enzymes. In Proteins, 74, 92-103. doi:10.1002/prot.22120. https://pubmed.ncbi.nlm.nih.gov/18615712/
5. Li, Xiaoping, Kim, Sang-Wook, Do, Kyoung-Tag, Choi, Bong-Hwan, Kim, Kwan-Suk. 2010. Analyses of porcine public SNPs in coding-gene regions by re-sequencing and phenotypic association studies. In Molecular biology reports, 38, 3805-20. doi:10.1007/s11033-010-0496-1. https://pubmed.ncbi.nlm.nih.gov/21107721/
6. Li, Changwei, Bazzano, Lydia A L, Rao, Dabeeru C, Lu, Xiangfeng, Kelly, Tanika N. 2015. Genome-wide linkage and positional association analyses identify associations of novel AFF3 and NTM genes with triglycerides: the GenSalt study. In Journal of genetics and genomics = Yi chuan xue bao, 42, 107-17. doi:10.1016/j.jgg.2015.02.003. https://pubmed.ncbi.nlm.nih.gov/25819087/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research